Femtech is one of the fastest-growing sectors in digital health. From period and fertility tracking to menopause support, pregnancy care, and sexual health, femtech products are reshaping how women understand and manage their bodies. But the very data that makes these tools powerful – deeply personal, intimate health information – also makes femtech uniquely sensitive.
Which is why transparency and privacy are not optional features or regulatory afterthoughts, they are the foundation of trust, adoption, and long-term success.
Femtech’s promise – and its responsibility
For decades, women’s health was under-researched, underfunded, and often treated as an afterthought in both medicine and technology. Femtech exists, largely, to correct this historic imbalance.
The rise of femtech has helped to address this gap by creating tools designed specifically around women’s biological realities and life stages. Millions of women now use apps to track menstrual cycles, fertility, pregnancy symptoms, or menopause-related changes, gaining insights that were previously inaccessible or ignored.
However, this progress comes with responsibility. Femtech developers handle some of the most sensitive information imaginable. This can include menstrual cycles, sexual activity, fertility struggles, pregnancy loss, mental health indicators, and medical diagnoses. When users share this information, they are placing an extraordinary level of trust in the platforms they use. If that trust is broken, through unclear data practices, unexpected data sharing, or security failures, the consequences are far more serious than with most other consumer apps.
Why transparency is non-negotiable
Transparency is the cornerstone of trust in femtech, because users need to know exactly what data is being collected, how it is used, who it is shared with, and why. Research and regulatory reviews have consistently shown that women care deeply about these questions. In fact, transparency and data security often rank higher than cost or ease of use when women choose a period or fertility tracking app.
The problem is that transparency is frequently undermined by complex, legalistic privacy policies and bundled consent models. Many apps still require users to agree to lengthy terms of service that combine essential functionality with optional data sharing, advertising, or analytics. In practice, this means users may “consent” to data practices they do not fully understand or genuinely agree with. In the context of femtech, this approach is particularly problematic because the stakes are so high.
True transparency goes beyond legal compliance. It means presenting information in clear, accessible language, offering meaningful choices, and allowing users to change their minds. It also means being upfront about trade-offs. For example, explaining how certain features rely on data sharing, and what happens if a user opts out. When transparency is done well, it empowers users rather than overwhelming them.
Privacy risks are not hypothetical
Privacy risks in femtech are not abstract or theoretical. Reviews by digital health organisations such as ORCHA and consumer advocacy groups have highlighted ongoing concerns around data sharing with third parties, particularly advertisers and analytics providers.
Some users have reported an increase in baby or fertility-related advertising after using period or fertility apps. Which can be distressing experiences, especially for those dealing with miscarriage, infertility, or complex reproductive choices.
Beyond advertising, there are broader societal and legal risks. In certain jurisdictions, women’s reproductive rights are restricted or subject to rapid change. In these contexts, sensitive health data could potentially be misused, accessed by authorities, or exposed through data breaches. Even in regions with strong data protection laws, no system is immune to security failures. For femtech users, a breach can lead not only to embarrassment, but to discrimination, harassment, or real-world harm.
Personalisation vs. protection: finding the balance
One of femtech’s greatest strengths is personalisation. Tailored insights, reminders, educational content, and community features can make apps feel supportive, relevant, and genuinely helpful. But personalisation depends on profiling: drawing inferences from user data to predict needs or behaviours. Without clear boundaries, this can quickly cross into intrusion.
The challenge for femtech companies is to balance personalisation with protection. This means carefully assessing which data is truly necessary, minimising data collection where possible, and avoiding uses that could cause harm or distress. It also means being thoughtful about targeted content. For example, pregnancy-related notifications or advertisements may be helpful for some users and deeply painful for others. Ethical design requires anticipating these impacts, not simply optimising for engagement or revenue.
User control is central to trust
Privacy is not just about what companies do behind the scenes, it is also about user agency. Femtech users should be able to easily access, correct, delete, or export their data. They should be able to opt out of certain data uses without losing access to core features. Crucially, these controls should be intuitive and available throughout the user journey, not hidden behind support tickets or obscure settings.
When users feel in control of their data, trust grows. When they feel trapped or misled, trust evaporates. In a market built on intimate disclosure, losing trust can be fatal, not only for individual products, but for the reputation of the entire femtech sector.
Transparency and privacy as competitive advantages
For femtech founders and investors, transparency and privacy should be viewed not as constraints, but as strategic advantages. Regulators are paying closer attention to health apps, and expectations around accountability are rising. Companies that embed privacy-by-design principles early, through robust governance, clear consent mechanisms, and strong security practices, are better positioned to scale sustainably.
Most importantly, users notice. In a crowded market, trust can be a key differentiator. Femtech companies that clearly communicate their values, respect user autonomy, and demonstrate ethical leadership are more likely to earn long-term loyalty. In an industry built to empower women, aligning business practices with that mission is not just good ethics, it is good business.
The future of femtech depends on trust
Femtech has the potential to transform healthcare, challenge taboos, and close long-standing gender gaps in medicine and technology. But this potential can only be realised if users feel safe. Transparency and privacy are not secondary concerns, they are the conditions that make innovation possible.
As femtech continues to grow globally, the companies that succeed will be those that recognise a simple truth: when it comes to women’s health data, trust is everything. And trust is earned through openness, respect, and an unwavering commitment to protecting the people these technologies are meant to serve.